Sustained‐release of sclerostin single‐chain antibody fragments using poly(lactic‐co‐glycolic acid) microspheres for osteoporotic fracture repair

Osteoporotic fracture is one of the most common bone diseases in middle and old age, as the most serious consequence of osteoporosis. Sclerostin single‐chain antibody fragments (SCL‐scFv) have been proven to promote bone formation by binding to scleroprotein, a natural antagonist of the Wnt pathway,...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ming, Li, Shifei, Liu, Jianheng, Cui, Xiang, Zhang, Shudong, Zhou, Jian, Wang, Xiumei, Yao, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618085/
https://www.ncbi.nlm.nih.gov/pubmed/31012249
http://dx.doi.org/10.1002/jbm.a.36704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618085/
https://www.ncbi.nlm.nih.gov/pubmed/31012249
http://dx.doi.org/10.1002/jbm.a.36704

Ejemplares similares